![Kenneth Mills](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kenneth Mills
Fondatore presso
REGENXBIO INC.
Patrimonio netto: 5 M $ in data 31/07/2026
Profilo
Kenneth T.
Mills is the founder of REGENXBIO, Inc., founded in 2008, serving as Chairman since 2024.
Mr. Mills is currently Chief Executive Officer & Director at Tagworks Pharmaceuticals BV since 2024.
Former positions include Director-Business Development at IGEN International, Inc. from 1997 to 2003, Chief Financial Officer & VP-Business Development at Meso Scale Diagnostics LLC from 2004 to 2006, and Partner at FoxKiser LLP from 2007 to 2015.
Education includes an undergraduate degree from the Massachusetts Institute of Technology, conferred in 1997.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
REGENXBIO, INC. 0,76% | 29/05/2026 | 495.925 ( 0,76% ) | 5 M $ | 31/07/2026 |
Posizioni attive di Kenneth Mills
| Società | Posizione | Inizio |
|---|---|---|
| REGENXBIO INC. | Fondatore | 16/07/2008 |
Tagworks Pharmaceuticals BV
 Tagworks Pharmaceuticals BV BiotechnologyHealth Technology Develops biotechnology | Amministratore Delegato | 01/10/2024 |
Precedenti posizioni note di Kenneth Mills
| Società | Posizione | Fine |
|---|---|---|
FOXKISER LLP
 FOXKISER LLP Miscellaneous Commercial ServicesCommercial Services Provides strategic advice and counseling services | Corporate Officer/Principal | 01/01/2015 |
Meso Scale Diagnostics LLC
 Meso Scale Diagnostics LLC Medical SpecialtiesHealth Technology Develops and markets solutions for multiplex biological assays | Direttore Finanziario/CFO | 01/12/2006 |
IGEN International, Inc.
 IGEN International, Inc. Medical SpecialtiesHealth Technology Develops and markets biological testing systems that incorporate its proprietary electrochemiluminescence technology for used in drug discovery, diagnostic products development as well as food and environmental safety testing | Corporate Officer/Principal | 01/12/2003 |
Formazione di Kenneth Mills
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
89
Relazioni di 1° grado
6
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
REGENXBIO, Inc.
 REGENXBIO, Inc. Pharmaceuticals: MajorHealth Technology Develops gene therapy | Health Technology |
IGEN International, Inc.
IGEN International, Inc. Medical SpecialtiesHealth Technology Develops and markets biological testing systems that incorporate its proprietary electrochemiluminescence technology for used in drug discovery, diagnostic products development as well as food and environmental safety testing | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Meso Scale Diagnostics LLC
Meso Scale Diagnostics LLC Medical SpecialtiesHealth Technology Develops and markets solutions for multiplex biological assays | Health Technology |
FOXKISER LLP
FOXKISER LLP Miscellaneous Commercial ServicesCommercial Services Provides strategic advice and counseling services | Commercial Services |
Tagworks Pharmaceuticals BV
Tagworks Pharmaceuticals BV BiotechnologyHealth Technology Develops biotechnology | Health Technology |
